SCHEMBL574446

SCHEMBL574446

COC(=O)c1cc([N+](=O)[O-])c(Oc2ccc(F)cc2)c(S(=O)(=O)/N=C/N(C)C)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VCAM1 P19320 1/20 0.44
POLB P06746 2/20 0.43
MAPT P10636 2/20 0.43
HPGD P15428 2/20 0.42
ALDH1A1 P00352 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
USP10 Q14694 1/20 0.40
CRHBP P24387 1/20 0.37
CRHR2 Q13324 1/20 0.37
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
MEN1 O00255 2/20 0.36
LMNA P02545 2/20 0.36
KMT2A Q03164 2/20 0.36
THRB P10828 2/20 0.35
GAA P10253 1/20 0.35
XDH P47989 1/20 0.35
HSPB1 P04792 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL574447 1.00 VCAM1 (0.44) VCAM1POLBMAPTHPGDALDH1A1
SCHEMBL10224543 1.00 VCAM1 (0.44) VCAM1POLBMAPTHPGDALDH1A1
SCHEMBL11517426 0.93 VCAM1 (0.46) VCAM1POLBMAPTHPGDALDH1A1
SCHEMBL11510429 0.91 POLB (0.48) VCAM1POLBMAPTHPGDALDH1A1
SCHEMBL574048 0.91 TPMT (0.38) VCAM1POLBMAPTHPGDALDH1A1
SCHEMBL574046 0.91 TPMT (0.38) VCAM1POLBMAPTHPGDALDH1A1
SCHEMBL574029 0.91 VCAM1 (0.46) VCAM1POLBMAPTHPGDALDH1A1
SCHEMBL10222900 0.91 VCAM1 (0.46) VCAM1POLBMAPTHPGDALDH1A1
SCHEMBL574047 0.91 TPMT (0.38) VCAM1POLBMAPTHPGDALDH1A1
SCHEMBL573657 0.91 VCAM1 (0.46) VCAM1POLBMAPTHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598478-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE Neurotherapeutics Pharma, Inc. (US) 2013-06-05 EP disclosed
WO-2012018635-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE NEUROTHERAPEUTICS PHARMA, INC. (US) 2012-02-09 WO disclosed